Parents Choice Infant Acetaminophen Recalled for Contaminated Excipient
Perrigo Company is recalling approximately 55,656 bottles of Parents Choice Infants Pain and Fever (Acetaminophen) oral suspension nationwide due to CGMP deviations. The product was manufactured with a contaminated excipient that was recalled from the supplier.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The source identifies this as an FDA Class II recall involving a CGMP deviation with a contaminated excipient. The source text does not report any illnesses, injuries, or confirmed harm, and the hazard is related to a manufacturing practice deviation rather than a known high-risk pathogen. This fits the criteria for Moderate severity as a precautionary or quality-related recall.
Plain-English summary
Perrigo Company PLC is recalling approximately 55,656 bottles of Parents Choice Infants Pain and Fever (Acetaminophen) Dye Free Grape Oral Suspension (160mg/5ml, 2 FL OZ per bottle) distributed by Wal-Mart Stores, Inc. nationwide. The affected batch is 1CK1274 with expiration date 02/28/2023 (NDC: 49035-766-16).
The recall is due to Current Good Manufacturing Practice (CGMP) deviations. The products were manufactured using a contaminated excipient that was itself recalled by the excipient supplier.
Consumers who have purchased this product should stop using it. Patients with questions about this recall or the safety of their medication should contact their healthcare provider or pharmacist.
The recalled product
- Product
- PARENTS CHOICE INFANTS PAIN AND FEVER (ACETAMINOPHEN)
- Brand
- PARENTS CHOICE INFANTS PAIN AND FEVER
- Manufacturer
- Perrigo Company PLC
- Hazard
- contaminated-excipient
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1CK1274
- Exp 02/28/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27